Overall rank by patents
#29,043
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Inbios International, Inc.
USPTO PatentsView assignee record - 9 granted patents across 11 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
9
Total patents granted
11
CPC technology areas
22.0
Avg claims per patent
+250%
5-year filing velocity
The verdict
Inbios holds 9 US patents across 11 technology areas, rank #29,043 of 50,000 tracked assignees.
- #29,043
- of 50,000 US assignees by volume
- Top 21%
- by Innovation Score (46.2/100)
- 22.0
- avg claims per patent
- +250%
- filing velocity, last 5 yrs
Portfolio overview
Inbios International, Inc. has been granted 9 US utility patents between 2016 and 2025, placing Inbios International, Inc. at rank #29,043 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.0 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Inbios International, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Inbios sits between Impac Medical Systems, Inc. (9 patents, rank #29,039) and Infocus Corporation (9 patents, rank #29,047) - the closest US assignees by grant volume. The composite Innovation Score of 46.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 7 grants, compared with 2 in the 2015–2019 window, a +250% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Inbios International, Inc.'s 22.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Inbios International, Inc. against peers pursuing similar technology classes.
Who files at Inbios's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Impac Medical Sys…
IMPAC Medical Systems, Inc.
9 patents
- Imsol
IMSOL CORP.
9 patents
- IN Ingredients
IN Ingredients, Inc.
9 patents
- In-tech Enterprise
IN-TECH ENTERPRISE LTD.
9 patents
- Incnetworks
INCNETWORKS, INC.
9 patents
- Indian Council OF…
INDIAN COUNCIL OF MEDICAL RESEARCH
9 patents
- Industrial Fence
INDUSTRIAL FENCE, INC.
9 patents
- Infocus
INFOCUS CORPORATION
9 patents
- Inbios Internatio… ◀
INBIOS INTERNATIONAL, INC.
9 patents
What this shows Inbios holds 9 patents at rank #29,043, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Inbios
By rank, the assignees closest to #29,043 in granted patent volume.
- Impac Medical Systems, Inc. #29,039 · 9 patents
- Imsol Corp. #29,040 · 9 patents
- IN Ingredients, Inc. #29,041 · 9 patents
- In-tech Enterprise Ltd. #29,042 · 9 patents
- Incnetworks, Inc. #29,044 · 9 patents
- Indian Council OF Medical Research #29,045 · 9 patents
- Industrial Fence, Inc. #29,046 · 9 patents
- Infocus Corporation #29,047 · 9 patents
Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)
Other assignees with the most granted patents in Inbios's primary technology class.
- The Regents Of The University Of California 1,153 in class
- Shimadzu Corporation 1,111 in class
- Saudi Arabian OIL Company 837 in class
- Halliburton Energy Services, Inc. 816 in class
- The Boeing Company 701 in class
- General Electric Company 634 in class
- Kla-tencor Corporation 583 in class
- Massachusetts Institute Of Technology 530 in class
Inbios's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 21% higher than 79% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 11.1% |
| 2018 | 1 | 11.1% |
| 2021 | 2 | 22.2% |
| 2023 | 1 | 11.1% |
| 2024 | 3 | 33.3% |
| 2025 | 1 | 11.1% |
Which technologies does Inbios International, Inc. patent most?
Top 11 of 11 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Accelerating
Frequently Asked Questions
How many patents does Inbios International, Inc. hold?
Inbios International, Inc. holds 9 US granted patents filed between 2016 and 2025, spanning 11 technology areas.
What is Inbios International, Inc.'s Innovation Score?
Inbios International, Inc. has an Innovation Score of 46.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Inbios International, Inc. focus on?
Inbios International, Inc.'s top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 8 patents. The company has filed patents in 11 CPC subclasses total.
Is Inbios International, Inc.'s patent filing rate increasing or decreasing?
Inbios International, Inc.'s recent filing velocity is +250% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Inbios International, Inc.'s patents?
Inbios International, Inc.'s patents average 22.0 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Inbios International, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Inbios's 9 grants land it in the top 21% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Inbios ranks #29,043 of 50,000. Top 50 holders
- Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.